...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: debenture

Yeah, you're right Buckeyes.  If a Covid trial didn't work out that makes it much harder to get a BoM2 going.  Might actually kill the whole thing.  BoM2 should, based on the initial trial, have (with revised endpoints) a far better chance of success.

Share
New Message
Please login to post a reply